Revolution Medicines, Valuation
| RVMDW Stock | 0.32 0.08 20.00% |
Revolution Medicines, seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Revolution Medicines, from analyzing the company fundamentals such as EBITDA of (430.58 M), number of shares shorted of 446, and Return On Equity of -0.47 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Revolution Medicines,'s price fluctuation is out of control at this time. Calculation of the real value of Revolution Medicines, is based on 3 months time horizon. Increasing Revolution Medicines,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Revolution stock is determined by what a typical buyer is willing to pay for full or partial control of Revolution Medicines, Warrant. Since Revolution Medicines, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Revolution Stock. However, Revolution Medicines,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.32 | Real 0.26 | Hype 0.28 | Naive 0.41 |
The intrinsic value of Revolution Medicines,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Revolution Medicines,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Revolution Medicines, Warrant helps investors to forecast how Revolution stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Revolution Medicines, more accurately as focusing exclusively on Revolution Medicines,'s fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Revolution Medicines,'s intrinsic value based on its ongoing forecasts of Revolution Medicines,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Revolution Medicines,'s closest peers.
Revolution Medicines, Cash |
|
Revolution Valuation Trend
Analysing the historical paterns of Revolution Medicines,'s enterprise value and its market capitalization is a good way to estimate and gauge the value of Revolution Medicines, Warrant over time and is usually enough for investors to make rational market timing decisions.
Revolution Medicines, Total Value Analysis
Revolution Medicines, Warrant is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of 87.94 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Revolution Medicines, fundamentals before making investing decisions based on enterprise value of the companyRevolution Medicines, Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Revolution Medicines, has an asset utilization ratio of 0.56 percent. This indicates that the Company is making USD0.005617 for each dollar of assets. An increasing asset utilization means that Revolution Medicines, Warrant is more efficient with each dollar of assets it utilizes for everyday operations.Revolution Medicines, Profitability Analysis
The company reported the revenue of 11.58 M. Net Loss for the year was (436.37 M) with profit before overhead, payroll, taxes, and interest of 0.About Revolution Medicines, Valuation
Our relative valuation model uses a comparative analysis of Revolution Medicines,. We calculate exposure to Revolution Medicines,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Revolution Medicines,'s related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 11.6 M | 12.2 M | |
| Pretax Profit Margin | (37.99) | (36.09) | |
| Operating Profit Margin | (42.07) | (39.97) | |
| Net Loss | (37.68) | (35.80) | |
| Gross Profit Margin | 0.65 | 0.69 |
Revolution Medicines, Growth Indicators
Investing in growth stocks can be very risky. If the company such as Revolution Medicines, does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 113.1 M |
Revolution Medicines, Current Valuation Indicators
Valuation refers to the process of determining the present value of Revolution Medicines, Warrant and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Revolution we look at many different elements of the entity such as Revolution's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Revolution Medicines,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Revolution Medicines,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Revolution Medicines,'s worth.Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.